Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Lack of specific γ-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation

Blood (2009) 114 (14): 2888–2899.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals